GlassScriptPhysician profile
Jeffrey C Selan
NPI 1134480205
$6,743.14
in general payments reported to CMS, 2019-2025
28 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,232 · 2020: $329 · 2021: $679 · 2022: $547 · 2023: $699 · 2024: $1,086 · 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,956.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,334.51 | 2019-2025 | Mitraclip, Xience Skypoint |
| Abiomed | $1,028.98 | 2019-2025 | Impella |
| Medtronic, INC. | $699.80 | 2022-2025 | Symplicity G3, Ffrangio |
| Boston Scientific Corporation | $546.79 | 2019-2025 | Avvigo Guidance System |
| Shockwave Medical, INC | $511.65 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $422.04 | 2019-2022 | |
| Chiesi USA, INC. | $267.14 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $239.12 | 2019-2024 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $210.64 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $181.61 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $175.49 | 2024-2025 | Andexxa, Wainua |
| Edwards Lifesciences Corporation | $162.87 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Terumo Medical Corporation | $153.61 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $132.58 | 2023 | Artis Icono Biplane |
| Janssen Pharmaceuticals, INC | $110.83 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $107.61 | 2019 | |
| Amgen INC. | $84.84 | 2023-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $71.09 | 2022 | |
| Bridgebio Pharma, INC. | $54.21 | 2025 | Attruby |
| Novartis Pharmaceuticals Corporation | $50.31 | 2023-2025 | |
| Heartflow, INC. | $37.63 | 2025 | |
| Alnylam Pharmaceuticals INC. | $35.99 | 2025 | Onpattro |
| Pfizer INC. | $32.88 | 2023-2024 | |
| Novo Nordisk INC | $25.10 | 2025 | Wegovy |
| Cardiva Medical, INC. | $22.94 | 2019 | |
| Angiodynamics, INC. | $16.42 | 2023 | Alphavac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.76 | 2025 | Jardiance |
| Cardinal Health 200 LLC | $12.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Selan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.